Topics
CNS Tumors | Treatment | Theranostics
Home > Publications > Topics > CNS Tumors > Treatment > Theranostics
Albert NL, Le Rhun E, Minniti G, Mair MJ, Galldiks N, Tolboom N,
Jakola AS, Niyazi M, Smits M, Verger A, Cicone F, Weller M,
Preusser M; European Organisation for Research and Treatment of
Cancer Brain Tumor Group.
Translating
the theranostic concept to neuro-oncology: disrupting barriers.
Lancet
Oncol. 2024 Aug 27;25(9):e441-e451. doi:
10.1016/S1470-2045(24)00145-1. PMID:
39214115. Review˰ ˍ
Da Ros V, Filippi L, Garaci F.
Intra-arterial
administration of PSMA-targeted radiopharmaceuticals for brain
tumors: is the era of interventional theranostics next?
Expert
Rev Anticancer Ther. 2024 Aug 29:1-5. doi:
10.1080/14737140.2024.2398492. PMID:
39206859. Review˰ ˍ
Wen PY, Preusser M, Albert NL.
Design
and conduct of theranostic trials in neuro-oncology: Challenges
and opportunities.
Neuro
Oncol. 2024 Oct 5:noae162. doi:
10.1093/neuonc/noae162. PMID:
39368109. Review. ˍ
Albert NL, Preusser M.
Theranostics
and molecular imaging in Neuro-Oncology:
the beginning of a new era.
Neuro
Oncol. 2024 Nov 15:noae191. doi:
10.1093/neuonc/noae191. PMID:
39545472. Editorial. ˍ